EZH2 and small cell lung carcinoma: In order to increase the efficacy of expression of therapeutic genes in small lung cancer cell (SCLC), a chimeric double promoter based on promoters of the hASH1 and EZH2  genes with a high level of expression in SCLC cells was obtained.